HRT Addresses: Estrogen-driven fat redistribution, muscle loss prevention, sleep disruption, hot flashes and night sweats GLP-1 Addresses: Appetite dysregulation, insulin resistance, blood sugar instability, inflammation reduction Combined Benefit: Targets both hormonal AND behavioral factors, which can help preserve lean mass while losing fat and support better energy for lifestyle changes, leading to comprehensive quality of life improvement Rather than competing approaches, hormone optimization therapy and GLP-1 therapy can work through distinct physiological pathways that reinforce each other
Molina, C
Rybelsus (oral semaglutide 3 mg, 7 mg, and 14 mg) is FDA-approved for type 2 diabetes management, not for weight loss or obesity
Absence of ongoing diabetic complications (or if present, they are noted as sequelae) 5
But it should sit inside a real plan: Treat the OSA now (PAP, oral appliance, positional therapy, surgerydepending on your case) Treat the weight driver long-term (nutrition, activity, behavioral support, medication when appropriate) Reassess (repeat sleep testing after meaningful weight change) And if your OSA is mainly anatomy-driven, we should focus on the airway strategy, not chase weight loss alone
The choice depends on your preference and lifestyle